Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10919486 | Radiotherapy and Oncology | 2013 | 4 Pages |
Abstract
For APBI using the Mammosite applicator, EUD is higher than the marginal prescription dose and, for the dose-fractionation patterns considered here, was associated with acute and late skin toxicity. EUD is a potentially useful parameter to characterize non-uniform dose distributions related to brachytherapy treatments. Further evaluation in future studies is warranted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alexandra J. Stewart, Jaroslaw T. Hepel, Desmond A. O'Farrell, Phillip M. Devlin, Lori Lyn Price, Roger G. Dale, David E. Wazer,